A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors (Q84265156)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 June 2011
edit
Language Label Description Also known as
English
A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors
scientific article published on 03 June 2011

    Statements

    title
    A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    21638123
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21638123%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    2 February 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q84265156&oldid=2221561024"